{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:02:34Z","timestamp":1793638954858,"version":"4.5.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.obpill.2026.100249","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:48:46Z","timestamp":1770450526000},"page":"100249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prevalence and risk factors of sarcopenic obesity in Thai people with diabetes: A cross-sectional study"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5491-4766","authenticated-orcid":false,"given":"Thanapat","family":"Limpaarayakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8956-6378","authenticated-orcid":false,"given":"Kasidid","family":"Lawongsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2730-6646","authenticated-orcid":false,"given":"Methavee","family":"Poochanasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-8292","authenticated-orcid":false,"given":"Nattapol","family":"Sathavarodom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apussanee","family":"Boonyavarakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0695-9960","authenticated-orcid":false,"given":"Parinya","family":"Samakkarnthai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2026.100249_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","article-title":"Sarcopenic obesity in older adults: a clinical overview","volume":"20","author":"Prado","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.obpill.2026.100249_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"},{"issue":"1","key":"10.1016\/j.obpill.2026.100249_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.obpill.2026.100249_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/j.obpill.2026.100249_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3389\/fendo.2020.00568","article-title":"Diabetes and sarcopenic obesity: pathogenesis, diagnosis, and treatments","volume":"11","author":"Wang","year":"2020","journal-title":"Front Endocrinol"},{"issue":"9","key":"10.1016\/j.obpill.2026.100249_bib6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2174\/1573399816666200109091449","article-title":"Understanding sarcopenic obesity in terms of definition and health consequences: a clinical review","volume":"16","author":"Nezameddin","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.obpill.2026.100249_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","article-title":"Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.obpill.2026.100249_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/path.4674","article-title":"Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway","volume":"238","author":"Chiu","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.obpill.2026.100249_bib9","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.2337\/dc19-S012","article-title":"12. Older adults: standards of medical care in Diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2026.100249_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.783363","article-title":"Sarcopenia is associated with a risk of mortality in people with type 2 diabetes mellitus","volume":"12","author":"Takahashi","year":"2021","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.obpill.2026.100249_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13395-022-00309-5","article-title":"The prevalence of low muscle mass associated with obesity in the USA","volume":"12","author":"Murdock","year":"2022","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.obpill.2026.100249_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clnesp.2023.09.920","article-title":"Prevalence of sarcopenic obesity in patients with diabetes and adverse outcomes: a systematic review and meta-analysis","volume":"58","author":"Zhou","year":"2023","journal-title":"Clin Nutr ESPEN"},{"issue":"3","key":"10.1016\/j.obpill.2026.100249_bib13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"Suppl 3","key":"10.1016\/j.obpill.2026.100249_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"AMERICAN association of clinical endocrinologists and AMERICAN college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"9403","key":"10.1016\/j.obpill.2026.100249_bib15","first-page":"157","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies [published correction appears in Lancet. 2004 Mar 13;363(9412):902]","volume":"363","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.obpill.2026.100249_bib16","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.obpill.2026.100249_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clnesp.2023.09.920","article-title":"Prevalence of sarcopenic obesity in patients with diabetes and adverse outcomes: a systematic review and meta-analysis","volume":"58","author":"Zhou","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.obpill.2026.100249_bib18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2147\/DMSO.S360942","article-title":"Sarcopenic obesity with normal body size may have higher insulin resistance in elderly patients with type 2 diabetes mellitus","volume":"15","author":"Han","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.obpill.2026.100249_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1186\/s12877-022-03471-z","article-title":"The prevalence and risk factors of sarcopenia among Thai community-dwelling older adults as defined by the Asian working group for sarcopenia (AWGS-2019) criteria: a cross-sectional study","volume":"22","author":"Sri-On","year":"2022","journal-title":"BMC Geriatr"},{"issue":"1","key":"10.1016\/j.obpill.2026.100249_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/nu13010183","article-title":"A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors","volume":"13","author":"Izzo","year":"2021","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.obpill.2026.100249_bib21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1507\/endocrj.EJ20-0655","article-title":"Sarcopenic obesity is associated with macroalbuminuria in patients with type 2 diabetes: a cross-sectional study","volume":"68","author":"Takahashi","year":"2021","journal-title":"Endocr J"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:09:44Z","timestamp":1780060184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368126000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":21,"alternative-id":["S2667368126000057"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100249","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and risk factors of sarcopenic obesity in Thai people with diabetes: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100249"}}